SCHEMBL11234801

SCHEMBL11234801

Nc1cccc(NCc2ccc3c(c2)OCO3)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
INSR P06213 2/20 0.57
IGF1R P08069 2/20 0.57
SRC P12931 1/20 0.57
MAPT P10636 6/20 0.56
ALDH1A1 P00352 6/20 0.56
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
KDM4E B2RXH2 3/20 0.56
MAPK1 P28482 3/20 0.56
LMNA P02545 3/20 0.56
USP2 O75604 2/20 0.56
ALOX12 P18054 2/20 0.56
THRB P10828 1/20 0.56
HPGD P15428 1/20 0.56
CASP1 P29466 1/20 0.56
HTT P42858 1/20 0.56
CASP7 P55210 1/20 0.56
HBB P68871 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
TDP1 Q9NUW8 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11248884 0.99 INSR (0.56) INSRIGF1RSRCMAPTALDH1A1
Hydrochloric Acid SCHEMBL462937 0.99 INSR (0.56) INSRIGF1RSRCMAPTALDH1A1
SCHEMBL2979012 0.84 MAPT (0.64) INSRIGF1RSRCMAPTALDH1A1
SCHEMBL9672474 0.83 MAPT (0.63) INSRIGF1RSRCMAPTALDH1A1
SCHEMBL10057818 0.83 INSR (0.77) INSRIGF1RSRCMAPTALDH1A1
SCHEMBL13605307 0.83 MAPT (0.59) INSRIGF1RSRCMAPTALDH1A1
Hydrochloric Acid SCHEMBL2989075 0.82 MAPT (0.63) INSRIGF1RSRCMAPTALDH1A1
SCHEMBL11935927 0.81 MAPT (0.73) INSRIGF1RSRCMAPTALDH1A1
SCHEMBL19145014 0.78 MEN1 (0.53) INSRIGF1RSRCMAPTALDH1A1
SCHEMBL11248387 0.78 MAOA (0.48) MAPTALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2563508-B1 DELIVERY PARTICLE PROCTER & GAMBLE (US) 2019-07-10 EP disclosed
EP-2687287-A2 Delivery particles The Procter and Gamble Company (US) 2014-01-22 EP disclosed
US-20090318438-A1 Heterocyclic compounds and their use as anticancer agents CHEN XIAOLING 2009-12-24 US disclosed
US-4325704-A CONTAINING A DEVELOPER AND AN N-BENZYL-M-PHENYLENEDIAMINE DERIVATIVE AS A COUPLER HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1982-04-20 US disclosed
EP-0024660-A2 Hair dyeing substances Henkel Kommanditgesellschaft auf Aktien (DE) 1981-03-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318438-A1 Heterocyclic compounds and their use as anticancer agents TP53, MCL1, VHL INSR 3244/4885IGF1R 2345/4885SRC 1182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.